... the protection of amifostine. In an ongoing phase III study, we included 37 patients. Results: Amifostine’s integration into the simultaneous RCT in head and neck cancer patients was very easy and led to a significant reduction of mucositis, dysphagia, and xerostomia as the main nonhe-matological side effects...

...M.P. Prim; J.I. De Diego; P. Moreno; J. Garcia; J. Gavilán Objective: To assess the possible differences between right and left internal jugular veins in head and neck cancer patients, in order to choose one of them for cannulation. Patients and Methods: A prospective study was designed including...

..., unselected cohorts of consecutive patients from a university-based referral center that prefers transoral laser surgery over open surgical approaches for all head and neck cancer cases if such an approach is considered feasible and oncologically sound by the contributing surgeons at our department. It seeks...